SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-013767
Filing Date
2019-05-16
Accepted
2019-05-16 17:14:06
Documents
1
Period of Report
2019-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6369
  Complete submission text file 0000899243-19-013767.txt   7822
Mailing Address C/O KERYX BIOPHARMACEUTICALS INC ONE MARINA PARK DRIVE BOSTON MA 02210
Business Address
ROGERS MICHAEL W (Reporting) CIK: 0001244159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 19833269

Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Issuer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences